Therapies in the Pipeline for Systemic Autoimmune Diseases
The current goals in the development of novel therapeutics of systemic autoimmune diseases are to develop agents more effective than conventional therapies as well as to reduce the risk of organ damage. To achieve this goal, large multicentre randomised controlled trials are needed to confirm the ef...
| Main Authors: | , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
European Medical Journal
2016-07-01
|
| Series: | European Medical Journal Rheumatology |
| Subjects: | |
| Online Access: | http://emjreviews.com/wp-content/uploads/Therapies-in-the-Pipeline-for-Systemic-Autoimmune-Diseases1.pdf |